Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 01, 2013

SKLAR v. AMARIN CORPORATION PLC et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 27, 2016

    Amarin Again Dodges Securities Suit Over Vascepa Denial

    A New Jersey federal judge on Tuesday again dismissed a securities class action against biopharmaceuticals maker Amarin claiming it failed to fully inform investors about its progress during a failed bid to obtain approval for the expanded use of its fish oil drug Vascepa, saying no identified statements were materially false or misleading.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login